Bausch Health Companies (BHC) Dividends payables (2009 - 2010)

Bausch Health Companies' (BHC) quarterly Dividends payables came in at $15.1 million in Q3 2010, up 5.88% year-on-year from $14.2 million in Q3 2009, and up 5.77% quarter-over-quarter from $14.3 million in Q2 2010.

Bausch Health Companies (BHC) Dividends payables (2009 - 2010) Analysis & Trends

Bausch Health Companies has disclosed Dividends payables across 2 years of filings, most recently posting $15.1 million for Q3 2010.

  • Dividends payables for Q3 2010 came in at $15.1 million, up 5.88% year-over-year; the trailing twelve-month figure through Sep 2010 was $15.1 million (up 5.88% YoY), and the FY2009 annual result was $14.2 million, changed N/A from the prior year.
  • Dividends payables came in at $15.1 million for Q3 2010 at Bausch Health Companies, up from $14.3 million in the prior quarter.
  • In the past five years, Dividends payables ranged from a high of $59.3 million in Q2 2009 to a low of $14.2 million in Q3 2009.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dividends payables (Qtr)
1 Teva Pharmaceutical Industries 38.34 Bn 34.60 Bn 1.97 Bn -
2 Zoetis 33.27 Bn 31.33 Bn 1.62 Bn 224.00 Mn
3 United Therapeutics 23.75 Bn 21.60 Bn 648.10 Mn -
4 Aurora Cannabis 17.11 Bn 17.03 Bn 33.43 Mn -
5 Neurocrine Biosciences 16.37 Bn 15.05 Bn 800.70 Mn -
6 Elanco Animal Health 11.78 Bn 11.35 Bn 785.00 Mn -
7 Alkermes 7.05 Bn 6.54 Bn -116.06 Mn -
8 Lantheus Holdings 6.49 Bn 5.99 Bn 230.92 Mn -
9 Hims & Hers Health 6.19 Bn 5.44 Bn 396.79 Mn -
10 Bausch Health Companies 1.91 Bn 1.58 Bn 2.48 Bn -

Historic Data

Download Data
DateValue
Sep 30, 2010 15.08 Mn
Jun 30, 2010 14.26 Mn
Dec 31, 2009 14.25 Mn
Sep 30, 2009 14.24 Mn
Jun 30, 2009 59.33 Mn